scispace - formally typeset
C

Candice Estellat

Researcher at University of Paris

Publications -  63
Citations -  2200

Candice Estellat is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 18, co-authored 53 publications receiving 1714 citations. Previous affiliations of Candice Estellat include Paris Diderot University & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

TL;DR: This study classifies blinding methods and provides a detailed description of methods that could overcome some barriers of blinding in clinical trials assessing nonpharmacological treatment, and provides information for readers assessing the quality of results of such trials.
Journal ArticleDOI

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.

TL;DR: Immune reconstitution inflammatory syndrome (IRIS) occurred in 16 of 37 antiretroviral-naive patients who were treated subsequently for tuberculosis and human immunodeficiency virus (HIV) type 1 infection.
Journal ArticleDOI

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre-Louis Tharaux, +600 more
TL;DR: Anakinra did not improve outcomes in patients with mild-to-moderate COVID-19 pneumonia, and further studies are needed to assess the efficacy of anakinra in other selected groups of patients with more severe CO VID-19.
Journal ArticleDOI

Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review

TL;DR: A systematic review of all reports of randomized controlled trials assessing pharmacologic treatments with blinding published in 2004 in high impact-factor journals from Medline and the Cochrane Methodology Register provided a detailed description of methods that could help trialists overcome some barriers to blinding in clinical trials and readers interpret the quality of pharmalogic trials.